Avadel Pharmaceuticals plc (NASDAQ:AVDL) announced it will present 14 new abstracts, including four ...
– 14 abstracts accepted, including four oral presentations – – Interim analysis of real-world REFRES...
The average of price targets set by Wall Street analysts indicates a potential upside of 97.7% in Av...
DUBLIN, Ireland, May 29, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a bioph...
Two Seas Capital LP raised its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by...